Clinical

NAPRA seeks comments on drug schedule change for pediatric loratadine products

National Drug Scheduling Advisory Committee issues interim recommendations on drug schedule status change for loratadine products used in children two to 11 years of age.
Feds launch new Model Practice Standard for MAiD

The new model aims to help clinicians and regulators alike through complex cases.
B.C. to announce plan for access to diabetes drug Ozempic, hyped for weight loss

Adrian Dix said in January that the government would be investigating why almost 10% of prescriptions for the drug in B.C. were filled for American citizens.
What to know about new research on coffee and heart risks

In the U.S., more Americans drink coffee daily than tap water—but what does it mean for their hearts?
Doctors may miss how addiction patients cheat drug tests

Doctors often use urine tests to make sure patients taking medication for opioid addiction are sticking with treatment. A new study suggests they may be missing some cheaters.
QUIZ: How much do you know about endometriosis?

Test your knowledge on the diagnosis and management of endometriosis.
What risk factors appear associated with getting long-COVID?

Meta-analysis examines demographic characteristics and comorbidities associated with an increased risk of developing post-COVID-19 condition.
Seizure drug could extend survival time of donor organs

Strategy could mean more hearts available for transplant.